What is the share price of MedPlus Health Services Limited (MEDPLUS) today?
The share price of MEDPLUS as on 18th November 2026 is ₹600.40. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on MedPlus Health Services Limited (MEDPLUS) share?
The past returns of MedPlus Health Services Limited (MEDPLUS) share are- Past 1 week: -0.43%
- Past 1 month: -1.10%
- Past 3 months: -9.69%
- Past 6 months: -35.30%
- Past 1 year: -23.74%
- Past 3 years: -26.64%
- Past 5 years: -46.45%
What are the peers or stocks similar to MedPlus Health Services Limited (MEDPLUS)?
The peers or stocks similar to MedPlus Health Services Limited (MEDPLUS) include:What is the market cap of MedPlus Health Services Limited (MEDPLUS) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of MedPlus Health Services Limited (MEDPLUS) is ₹7211.21 Cr as of 18th November 2026.What is the 52 week high and low of MedPlus Health Services Limited (MEDPLUS) share?
The 52-week high of MedPlus Health Services Limited (MEDPLUS) is ₹1022.20 and the 52-week low is ₹565.60.What is the PE and PB ratio of MedPlus Health Services Limited (MEDPLUS) stock?
The P/E (price-to-earnings) ratio of MedPlus Health Services Limited (MEDPLUS) is 32.83. The P/B (price-to-book) ratio is 3.65.Which sector does MedPlus Health Services Limited (MEDPLUS) belong to?
MedPlus Health Services Limited (MEDPLUS) belongs to the Communication Services sector & Online Services sub-sector.How to buy MedPlus Health Services Limited (MEDPLUS) shares?
You can directly buy MedPlus Health Services Limited (MEDPLUS) shares on Tickertape. Simply sign up, connect your demat account and place your order.
MedPlus Health Services Limited
MEDPLUS Share Price
NSEMEDPLUS Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
MEDPLUS Performance & Key Metrics
MEDPLUS Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 34.17 | 3.65 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 78.69 | 5.47 | 0.69% |
from 7 analysts
Price Upside
Earnings Growth
Rev. Growth
MEDPLUS Company Profile
Medplus Health Services Pvt Ltd is an India-based retail pharmacy company. The Company helps customers to access its products, bills and all health records through online store, medplusmart.com, or on mobile through the MedPlus application.
MEDPLUS Sentiment Analysis
MEDPLUS Sentiment Analysis
MEDPLUS Stock Summary · July 2026
Management framed the quarter as one of rapid network expansion and solid underlying pharmacy-led growth, while also acknowledging margin pressure from rising employee costs and a still-developing franchise model. Q1 FY27 store count reached 5,476 after 146 net additions, with pharmacy revenue up 21.8% year over year and consolidated revenue at INR18,796 million, producing operating EBITDA of INR651 million and a 3.5% margin. Management said pharmacy remains the core driver as the store base scales, and noted that older stores are much more productive, with locations older than 12 months generating 94% of pharmacy sales and a 10.4% store-level EBITDA margin. At the same time, franchise stores made up 131 of the quarter’s 146 net additions, well above earlier expectations, and management described the model as strategically important but still being refined. They also discussed pricing and fee changes to support profitability, while employee expense pressure from wage hikes and new warehouse staffing was expected to weigh more fully in coming quarters. Near term, the company kept its FY27 target of 800 net new stores and said core store and warehousing investment will continue, while discretionary capex remains on hold.
MEDPLUS Stock Growth Drivers
MEDPLUS Stock Growth Drivers
8Store Network Expansion and Franchise-Led Scaling
MedPlus continues to expand its store base at a strong pace, with 222 gross openings
Growing Core Pharmacy Business and Same-Store Momentum
The core pharmacy business delivered strong operating momentum, with pharmacy revenue up 21.8% year over
MEDPLUS Stock Challenges
MEDPLUS Stock Challenges
8Capex Freeze and Strategic Pause
The company has put all approved and planned capital expenditure on hold, including projects such
Employee Cost Inflation and Margin Pressure
Operating costs are rising materially because of added warehouse headcount, wage increases in Karnataka and
MEDPLUS Forecast
MEDPLUS Forecasts
Price
Revenue
Earnings
MEDPLUS Share Price Forecast
MEDPLUS Share Price Forecast
All values in ₹
All values in ₹
MEDPLUS Company Revenue Forecast
MEDPLUS Company Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
MEDPLUS Stock EPS (Earnings Per Share) Forecast
MEDPLUS Stock EPS (Earnings Per Share) Forecast
All values in ₹
All values in ₹
MEDPLUS
MEDPLUS
Income
Balance Sheet
Cash Flow
MEDPLUS Income Statement
MEDPLUS Income Statement
| Quarter | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | sep 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,497.54 | 1,587.77 | 1,573.96 | 1,525.40 | 1,557.65 | 1,696.80 | 1,824.36 | 1,884.98 | 1,899.43 | 2,057.65 | ||||||||||
| Operating & Other expenses | 1,395.06 | 1,451.73 | 1,428.92 | 1,373.24 | 1,411.90 | 1,530.48 | 1,647.50 | 1,695.21 | 1,746.36 | 1,867.05 | ||||||||||
| EBITDA | 102.48 | 136.04 | 145.04 | 152.16 | 145.75 | 166.32 | 176.86 | 189.77 | 153.07 | 190.60 | ||||||||||
| Depreciation/Amortization | 60.03 | 63.14 | 62.47 | 64.21 | 65.62 | 68.56 | 72.74 | 75.95 | 77.92 | 83.83 | ||||||||||
| PBIT | 42.45 | 72.90 | 82.57 | 87.95 | 80.13 | 97.76 | 104.12 | 113.82 | 75.15 | 106.77 | ||||||||||
| Interest & Other Items | 24.66 | 25.12 | 25.97 | 26.84 | 27.37 | 28.82 | 30.83 | 33.48 | 33.27 | 36.62 | ||||||||||
| PBT | 17.79 | 47.78 | 56.60 | 61.11 | 52.76 | 68.94 | 73.29 | 80.34 | 41.88 | 70.15 | ||||||||||
| Taxes & Other Items | 3.42 | 9.05 | 10.71 | 9.78 | 10.40 | 13.43 | 15.48 | 16.36 | 8.70 | 14.07 | ||||||||||
| Net Income | 14.37 | 38.73 | 45.89 | 51.33 | 42.36 | 55.51 | 57.81 | 63.98 | 33.18 | 56.08 | ||||||||||
| EPS | 1.20 | 3.24 | 3.84 | 4.32 | 3.54 | 4.63 | 4.82 | 5.33 | 2.76 | 4.73 |
MEDPLUS Company Updates
Investor Presentation
MEDPLUS Stock Peers
MEDPLUS Past Performance & Peer Comparison
MEDPLUS Past Performance & Peer Comparison
Communication ServicesOnline Services
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| MedPlus Health Services Limited | 32.83 | 3.65 | — |
| Eternal Limited | 921.28 | 10.89 | — |
| One 97 Communications Ltd | 166.45 | 7.57 | — |
| Info Edge (India) Ltd | 52.79 | 1.85 | 0.73% |
MEDPLUS Stock Price Comparison
Compare MEDPLUS with any stock or ETFMEDPLUS Holdings
MEDPLUS Shareholdings
MEDPLUS Promoter Holdings Trend
MEDPLUS Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
A significant proportion of promoter holdings is pledged
MEDPLUS Institutional Holdings Trend
MEDPLUS Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has decreased by 1.80%
MEDPLUS Shareholding Pattern
MEDPLUS Shareholding Pattern
MEDPLUS Shareholding History
MEDPLUS Shareholding History
Mutual Funds Invested in MEDPLUS
Mutual Funds Invested in MEDPLUS
No mutual funds holding trends are available
Top 5 Mutual Funds holding MedPlus Health Services Limited
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 4.1758% | Percentage of the fund’s portfolio invested in the stock 4.30% | Change in the portfolio weight of the stock over the last 3 months 0.50% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 8/45 (+1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 3.0340% | Percentage of the fund’s portfolio invested in the stock 1.16% | Change in the portfolio weight of the stock over the last 3 months -0.17% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 35/82 (-6) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 2.8359% | Percentage of the fund’s portfolio invested in the stock 2.26% | Change in the portfolio weight of the stock over the last 3 months -0.43% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 16/40 (-5) |
Compare 3-month MF holding change on Screener
smallcases containing MEDPLUS stock
smallcases containing MEDPLUS stock
Looks like this stock is not in any smallcase yet.
MEDPLUS Events
MEDPLUS Events
MEDPLUS Dividend Trend
MEDPLUS has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
MEDPLUS Dividend Trend
MEDPLUS has not given any dividends in last 5 years
MEDPLUS Dividends
MEDPLUS Dividends
MEDPLUS Stock News & Opinions
MEDPLUS Stock News & Opinions
Medplus Health Services Limited announced it bought back 6,00,000 equity shares on November 18, 2026, through an open offer pursuant to the Securities and Exchange Board of India (Buyback of Securities) Regulations 2018, according to a filing with the BSE Limited and National Stock Exchange of India Limited.
Medplus Health Services Limited announced that it bought back 1,50,000 equity shares through an open offer on November 17, 2026, at an average acquisition price of Rs 609.4856 per share, bringing the total number of equity shares bought back to 6,00,000.
Medplus Health Services Limited announced it bought back 300,000 equity shares through an open offer on November 16, 2026, utilizing Nuvama Wealth Management Limited as a broker, with an average acquisition price of Rs 618.6321 per share, bringing the total equity shares bought back to 450,000.
Medplus Health Services Limited announced it bought back 1,50,000 equity shares on November 13, 2026, through an open offer, according to a regulatory filing with the BSE Limited and National Stock Exchange of India Limited. The average acquisition price was Rs 621.44 per share, excluding transaction costs, with Nuvama Wealth Management Limited acting as the broker.
Medplus Health Services Limited has pledged equity shares, primarily to secure Non-Convertible Debentures (NCDs) issued by Agilemed Investments Private Limited and Lone Furrow Investments Private Limited, with promoter Madhukar Reddy Gangadi involved in the transactions. The pledges were largely undertaken to maintain the Security Cover Ratio for existing NCDs, although in some instances, borrowed funds were used to retire previously outstanding NCDs. Lone Furrow Investments Private Limited assumed NCDs previously held by Dureleg Manufacturing Private Limited following an amalgamation. The transactions were primarily intended to support the existing debt obligations of Medplus Health Services and did not represent new borrowing, according to the documentation.
Medplus Health Services Limited disclosed that shares of the company have been encumbered to secure debt obligations for both the listed company and its promoter, Madhukar Reddy Gangadi. The pledges are primarily linked to the retirement of Non-Convertible Debentures (NCDs) issued by Agilemed Investments Private Limited and Lone Furrow Investments Private Limited, with some additional pledges intended to maintain the Security Cover Ratio for existing debt. As of November 10, 2023, Madhukar Reddy Gangadi pledged 4,500,000 shares, valued at approximately Rs 1.07 billion, while Medplus Health Services Limited pledged 1,800,000 shares, valued at approximately Rs 436.7 million. Catalyst Trustees Limited serves as the security trustee for the NCD holders.
Medplus Health Services Limited has engaged in a series of pledge and release transactions involving its equity shares, primarily to secure Non-Convertible Debentures (NCDs) issued by Agilemed Investments Private Limited and Lone Furrow Investments Private Limited. Between December 2023 and February 2024, the company pledged shares valued at a total of over Rs 139 crore, with additional pledges in September and October 2026 totaling 23 lakh shares to maintain Security Cover Ratios. Promoter Madhukar Reddy Gangadi was involved in these transactions, which were partly intended to retire existing NCDs and maintain the SCR without fresh borrowing. Significant share releases occurred on August 21, 2024, valued at approximately Rs 4.39 crore, and December 24, 2025, valued at roughly Rs 3.42 crore, based on closing prices at the time. The transactions are linked to a NCLT-sanctioned amalgamation that transferred NCDs between the two issuing entities.
Medplus Health Services Limited has undergone a series of share pledges and releases primarily to secure Non-Convertible Debentures (NCDs) issued by Agilemed Investments Private Limited and Lone Furrow Investments Private Limited. Promoter Madhukar Reddy Gangadi has been involved in multiple pledge and release transactions, with significant releases occurring in August 2024, valued at approximately Rs 4.39 crore, and December 2025, valued at roughly Rs 3.42 crore. The share pledges, which occurred between December 2023 and October 2026, were often related to maintaining the Security Cover Ratio and did not always involve fresh borrowing. Values of the pledged shares were calculated based on closing prices ranging from Rs 602.95 to Rs 766.05, with subsequent pledges occurring to restore the Security Cover Ratio.
MedPlus Health Services Limited will seek board approval on Friday, November 6, 2026, to consider a buyback of its fully paid-up equity shares, in accordance with the Securities and Exchange Board of India (Buy-back of Securities) Regulations, 2018, as amended. Trading window for designated persons will be closed from October 30, 2026, until 48 hours after the board meeting outcome is made public on the company website and the websites of BSE Limited and National Stock Exchange of India Ltd.
MedPlus Health Services Limited will seek board approval on Friday, November 6, 2026, to consider a proposal for a buyback of its fully paid-up equity shares, in accordance with the Companies Act, 2013, and the Securities and Exchange Board of India (Buy-back of Securities) Regulations, 2018. Trading window for designated persons will be closed from October 30, 2026, until 48 hours after the board meeting outcome is made public on the company website and the websites of BSE Limited and National Stock Exchange of India Ltd.
Over the last 5 years, revenue has grown at a yearly rate of 17.64%, vs industry avg of 45.49%
Over the last 5 years, market share decreased from 17.01% to 5.55%